T-cell factor/lymphoid enhancer factor (TCF/LEF) proteins regulate transcription by recruiting b-catenin and its associated co-regulators. Whether TCF/LEFs also recruit more factors through independent, direct interactions is not well understood. Here we discover Ring Finger Protein 14 (RNF14) as a new binding partner for all TCF/LEF transcription factors. We show that RNF14 positively regulates Wnt signalling in human cancer cells and in an in vivo zebrafish model by binding to target promoters with TCF and stabilizing b-catenin recruitment. RNF14 depletion experiments demonstrate that it is crucial for colon cancer cell survival. Therefore, we have identified a key interacting factor of TCF/b-catenin complexes to regulate Wnt gene transcription.
INTRODUCTION
Colorectal cancer is the most prominent cancer linked to misregulated Wnt signalling. Tumorigenesis is usually initiated by a loss-of-function mutation in the adenomatous polyposis coli gene, which encodes a component of the Destruction Complex for b-catenin degradation [1] . Thus, in colon cancer cells, Wnt signalling is constitutively active owing to b-catenin accumulation. Accumulated b-catenin translocates to the nucleus and interacts with T-cell factor/lymphoid enhancer factor (TCF/LEF) regulators to activate a gene transcription programme essential for colorectal adenoma formation. Wnt signalling also has critical roles in embryonic development and adult regeneration.
TCF transcription factors recognize specific DNA sequences referred to as Wnt response elements (WREs) with TLE transcription repressor complexes. These complexes are replaced by the co-activator b-catenin on Wnt stimulation or aberrant accumulation, and extensive studies have searched for b-catenin-interacting factors that counteract repressors to understand constitutive gene activation in cancer [2] .
b-catenin and its associated factors are recruited by TCF transcription factors that depend on cooperative interactions with other DNA-binding regulators [3] . However, owing to difficulties with purification of active TCF proteins, little is known about whether TCFs directly recruit more co-regulators that synergize with b-catenin for gene regulation. Here, we identify Ring Finger Protein 14 (RNF14) as a TCF-interacting co-regulator of Wnt signalling in cell culture and zebrafish models. We show that RNF14 is required for b-catenin association with WREs and that it has a critical role in developmental gene expression and cancer cell survival.
RESULTS AND DISCUSSION RNF14 associates with TCF transcription factors
To identify TCF-interacting cofactors, we performed a yeast-twohybrid screen using the DNA-binding domain (DBD) of human TCF1 as bait ( Fig 1A) . DBD contains the high mobility group box and the nuclear localization sequence. It is the most highly conserved domain among all TCF/LEFs and the only region capable of independent protein folding [4] . One group of complementary DNAs repeatedly isolated from the screen encodes RNF14, a highly conserved protein (supplementary Fig S1A online) . RNF14 is broadly expressed in human tissues and acts as a transcriptional co-activator of androgen receptor (AR)-mediated signalling through two functional domains: RING and AR-binding ( Fig 1A) [5] . RNF14 exhibits E3 ubiquitin ligase activities but its target substrates are unknown except RNF14 is a new co-activator of TCF/b-catenin complex B. Wu et al scientific report
for auto-ubiquitination [6] . We identified a sequence in the amino terminus with homology to ubiquitin-interacting motifs (UIMs, supplementary Fig S1A online) , suggesting that RNF14 binds ubiquitin.
To confirm interactions between RNF14 and TCFs, co-immunoprecipitation assays were performed in human embryonic kidney (HEK) 293T cells. TCF1 was detected by immunoprecipitation of Flag-RNF14 with an anti-Flag antibody, and RNF14 was present in a histidine (His)-tagged TCF1 pull-down with cobalt bead separation (Fig 1B) . Co-immunoprecipitation demonstrated that RNF14 also interacts with family members TCF4 (Fig 1C) , TCF3 and LEF1 (supplementary Fig S1B,C  online) . Intriguingly, a 10 kDa smaller, truncated isoform of TCF4 associated more strongly with RNF14 than full-length TCF4 (Fig 1C) . Western blot analysis with antibodies against either the carboxy or amino terminus of TCF4 showed that the smaller TCF4 polypeptide lacks the C terminus (supplementary Fig  S1D online) . In addition, a truncated peptide lacking the C-terminal half of RNF14 (D219-474, supplementary Fig S1A online) interacts with TCF4, indicating that it is the N-terminal half of RNF14 that mediates binding. RNF14 overexpression led to increased binding of b-catenin to TCF4 (Fig 1C) , suggesting that RNF14 stabilizes b-catenin/TCF interactions. We also performed co-immunoprecipitation in HCT116 colon cancer cells. We confirmed binding between endogenous RNF14, TCF4 and b-catenin (Fig 1D) . Thus, RNF14 binds all TCF members in a complex with b-catenin.
RNF14 promotes Wnt signalling in colon cancer cells
To test for a role of RNF14 in Wnt signalling, we used a TOPflash luciferase reporter with multimerized WREs driving luciferase expression. DLD1 colon cancer cells have high levels of active Wnt signalling, as shown by an 80-fold activation of TOPflash over a control reporter with mutant WREs (FOPflash; Fig 1E) . RNF14 overexpression enhanced reporter activity by 50% (Fig 1E) with a stronger dose-dependent activity in HCT116 cells, which have a lower baseline of Wnt signalling (Fig 1F) . Activation of TOPflash in HEK293T cells by overexpression of b-catenin was greatly enhanced by increasing levels of RNF14 (Fig 1G) . A co-transfected b-galactosidase control vector in which transcription is driven by a CMV promoter was not significantly affected by RNF14 (supplementary Fig S1E online) , suggesting that it is not a general transcriptional co-activator.
To map the TCF-interacting regions of RNF14, we constructed a series of glutathione S-transferase-tagged deletion mutants (supplementary Fig S2A online) for pull-down experiments with a recombinant, His-tagged DBD of TCF1. Deletion of the RING and AR domains in RNF14 did not alter binding to TCF, whereas an N-terminal deletion reduced the interaction (supplementary Fig S2B online) . Thus, RNF14 interacts with TCF, at least in part, through its N-terminal half, which contains the putative UIM. However, because the pull-down was performed with recombinant bacterial protein, this is independent of ubiquitin.
To assess functions of RNF14 domains in the HEK293T transfection assay, we expressed RNF14 deletion mutants lacking either the N terminus or the RING domain. Neither mutant promoted Wnt signalling efficiently (supplementary Fig S2C,D online), but both mutants were unstable as transiently expressed proteins (supplementary Fig S2C,D online) . In contrast, deletion of the AR domain enhanced the ability of RNF14 to promote transcription (supplementary Fig S2E online) , showing that its Wnt regulatory role does not involve AR signalling and might even be antagonized by AR. Finally, it has been reported that RNF14 can form a homodimer through its C terminus [7] . Indeed, deletion of this region (D380-474) dramatically reduced its effects on transcription (supplementary Fig S2E online) , suggesting that RNF14 dimerization could be important for regulation of Wnt signalling. This region also has a degenerate, but conserved RING domain (supplementary Fig S1A online) , which might serve a regulatory role.
RNF14 promotes Wnt signalling in zebrafish in vivo
Zebrafish Rnf14 is 59% similar in amino-acid sequence to human RNF14 (supplementary Fig S1A online Injection of mCherry and b-catenin mRNA was used as negative and positive controls, respectively. At B16 hpf in controls, weak endogenous Wnt activity was detected in the midbrain-hindbrain boundary region (Fig 2A) . As shown in two examples, Rnf14 mRNA injections dramatically increased Wnt signalling in this area, similar to that observed with b-catenin mRNA (Fig 2A,B) . This increase was not owing to morphological changes in the midbrain, as determined by expression of Otx2 (Fig 2A) . Importantly, while injected rnf14:mCherry was present throughout the embryo (Fig 2A) , Wnt signalling was only enhanced in specific regions such as the midbrain where Wnt activity is normally detected. There is no apparent, aberrant upregulation of Wnt signalling by overexpressed Rnf14 in other regions. These data demonstrate that Rnf14 is a signal amplifier that relies on endogenous Wnt signals for its action and overexpression itself cannot force ectopic activation.
We next measured changes in Wnt target gene expression in rnf14-injected embryos both during gastrulation (6 hpf) and at 24 hpf when signalling is strong in the midbrain. We performed quantitative reverse transcriptase PCR for three direct Wnt targets: the Wnt signalling component axin2 and transcription factors sp5 and lef1, which are overexpressed in colon cancer [9, 10] . Overexpression of full-length Rnf14 increased levels of Wnt target genes at 6 hpf ( Fig 2C) . The increase was less significant at 24 hpf (Fig 2D) , possibly owing to degradation of injected RNA. A Rnf14 deletion mutant lacking the putative AR domain (zebrafish Rnf14 D443-459, supplementary Fig S1A online) enhanced Wnt target gene expression while a larger deletion of the C terminus (Rnf14 D219-459) could not upregulate these targets. In fact, at 6 hpf, the C-terminal deletion mutant appeared to have dominantnegative effects on transcription (Fig 2C) . These results confirm that the AR interaction domain is not required for Rnf14 actions in Wnt signalling but that other more central regions are necessary. 
In addition to overexpression, we used morpholino oligonucleotides (MOs) to knockdown endogenous Rnf14. Co-injection of RNA encoding a mCherry reporter with the 25-nucleotide Rnf14-MO target sequence at its translation start site blocked expression starting at 2 ng MO per embryo (Fig 2E) . Increasing doses of MO did not affect Axin2 mRNA levels but reduced lef1 and sp5 at 10 ng per embryo (Fig 2F,G) . At this dosage and even higher, no overt morphological defects were observed. These data suggest that either knockdown is inefficient, possibly owing to maternally derived mRNA/protein (supplementary Fig S2F online) deposited before MO injection, or that Rnf14 shares redundant functions with other Rnf14-related genes (zebrafish have a second one with 65% similarity). Collectively, the overexpression and knockdown results indicate that Rnf14 is an important modulator of TCF/b-catenin-mediated transcription in vivo.
RNF14 upregulates Wnt targets in colon cancer cells
To define requirements for RNF14 in activation of the Wnt pathway in human cells, we used short interfering RNA (siRNA) to knock down expression in HEK293T and DLD1 cells by 70-80% (Fig 3A) . We treated HEK293T cells with 6-bromoindirubin-3 0 -oxime (BIO), a specific inhibitor of glycogen synthase kinase 3b, a kinase responsible for b-catenin phosphorylation and degradation. BIO induced Wnt signalling 100-fold and RNF14 depletion reduced this activation by 470% (Fig 3B) . In addition, RNF14 knockdown dramatically reduced Wnt3A-induced signalling in HEK293T cells as well as endogenous Wnt activity in colon cancer cells (Fig 3C,D) . Overexpression of an siRNA-resistant mutant of RNF14 rescued Wnt activity, confirming siRNA specificity (Fig 3E,F) . These results show that RNF14 is required for efficient activation of Wnt signalling in both colon cancer cells with high endogenous Wnt activity and normal cells stimulated by Wnt ligands.
We next tested if RNF14 affects expression of endogenous Wnt target genes, including AXIN2, LEF1, SP5 and the oncogene c-MYC. In DLD1 cells, RNF14 depletion reduced the expression of all these genes by 35-60% (Fig 3G) . Conversely, RNF14 overexpression increased expression levels 3-6-fold (Fig 3H) . Cyclin D1 (CCND1) is another known Wnt target gene that is reported to be upregulated by RNF14 in human glioblastoma cells [11] . However, we only detected a slight increase in CCND1 expression following RNF14 depletion in colon cancer cells (supplementary Fig S2G online) . This might reflect cell-typespecific roles for TCFs, which in some cases do not regulate CCND1 transcription, especially in the intestine [12] . RNF14 is a new co-activator of TCF/b-catenin complex B. Wu et al scientific report
RNF14 is required for colon cancer cell survival
To test if RNF14 has a bona fide functional role in colon cancer cell biology, cell growth assays were performed with depletion of RNF14. Knockdown of RNF14 in HCT116 and DLD1 colon cancer cells caused modest but not statistically significant reduction of cell growth (Fig 4A) . To test for survival activities, we plated siRNA-treated cells at low density and followed colony formation from single cells for 10 days. In contrast to the lack of RNF14 is a new co-activator of TCF/b-catenin complex B. Wu et al scientific report effect on proliferation, RNF14 depletion inhibited colony formation by 440% in HCT116 cells (Fig 4B,C) , and the reduction was more pronounced in DLD1 cells (490%) where more doses of siRNA were supplied during the 10 days (Fig 4C) . RNF14 depletion did not affect the average size of colonies or the morphology and size of individual cells (Fig 4B,D,E) . Importantly, colony formation could be rescued by overexpressing a TCF4-bcatenin fusion protein that constitutively activates transcription, implying that the effect of RNF14 depletion is specifically through reduction of TCF/b-catenin-mediated transcription (Fig 4F,G) . Therefore, RNF14 is not important for proliferation in vitro but is essential for colon cancer cell survival. From these in vitro studies, we conclude that RNF14 enables TCF/b-catenin to regulate a network of survival-connected Wnt target genes, which might include LEF1 as it is important for survival in other cancers [13] .
RNF14 stabilizes b-catenin binding to target promoters
RNF14 has long been known to co-activate transcription with AR; however, the mechanism of its co-activation is still unknown. To define the step at which RNF14 modulates Wnt signalling, we overexpressed a constitutively active, stable form of b-catenin (S33Y) to activate Wnt signalling in HEK293T cells. Co-expression of RNF14 enhanced the activity of S33Y b-catenin (Fig 5A) , suggesting that RNF14 can act downstream of b-catenin stabilization. This is further confirmed by the fact that the levels of nuclear b-catenin in DLD1 cells were not affected by RNF14 depletion (Fig 5B) .
In colon cancer cells, b-catenin is recruited by TCFs to WREs in target promoters such as AXIN2, SP5 and LEF1. To test for a role of RNF14 in recruitment, we utilized chromatin immunoprecipitation (ChIP) assays and observed that in HCT116 cells, RNF14 depletion reduced b-catenin enrichment at AXIN2 and LEF1 WREs by 40%-60% (Fig 5C,D) . Importantly, although RNF14 directly binds to TCF, it is not required for TCF association with the target site as knockdown had no effect on TCF occupancy (Fig 5E) . RNF14 depletion in BIO-treated HEK293T cells led to only modest decreases in b-catenin binding at the AXIN2 and SP5 promoters (Fig 5F,G) . GSK3b inhibitors lead to nuclear accumulation of large amounts of b-catenin protein, which rapidly cycles on and off target promoters [14] . It is therefore possible that artificially high levels of BIO-stabilized b-catenin overcome the reduction of RNF14 at target promoters. To test if RNF14 occupies WREs with TCF and b-catenin at target promoters, we performed ChIP assays with overexpressed Flag-tagged RNF14 in colon cancer cells (Fig 5H) . Similar to TCFs, RNF14 pre-occupies target sites in the absence of Wnt activity (Fig 5I,J) , and occupancy does not change when cells are treated with BIO. Taken together, our findings demonstrate that RNF14 occupies WREs and is required for efficient recruitment of b-catenin at Wnt target promoters.
In addition to enhancing b-catenin occupancy at Wnt target genes, RNF14 might provide complex functions in Wnt-regulated transcription as it is an E3 ligase with a putative UIM in its N terminus. Histone H2B monoubiquitination at Lys123 is required for activation of Wnt target genes [15] , and we therefore tested whether RNF14 regulates Wnt signalling through modulating H2B ubiquitination in the 'Wnt-ON' colon cancer cells. ChIP assays for ubiquitinated H2B in DLD1 cells revealed abundant H2B ubiquitination within the AXIN2 open reading frame (ORF) and in the 3 0 untranslated region (3 0 UTR) of SP5 but no ubiquitination was evident around RNF14-occupied WREs (supplementary Fig S2H online) . Therefore, RNF14 and H2B ubiquitination are detected at distinct locations. Furthermore, knockdown of RNF14 did not alter the level of ubiquitinated H2B at the ORF and 3 0 UTR regions (supplementary Fig S2H online) , suggesting that while it is an E3 ligase for ubiquitin, it does not affect H2B ubiquitination.
To activate gene expression, TCFs and b-catenin cooperate to create an enhanceosome that excludes corepressors such as TLEs and HDACs, and includes other tissue-specific factors, histone modifiers and extra auxiliary regulators [2] . Our findings reveal RNF14 to be a new cofactor that binds to TCFs and co-occupies Wnt target promoters. On its own, RNF14 overexpression cannot induce Wnt signalling. Therefore, RNF14 is a Wnt signal amplifier and not a signal generator; that is, it relies on bona fide Wnt signals or overexpressed b-catenin for its activities. Here, we provide both in vitro and in vivo evidence that RNF14 specifically promotes Wnt signalling through a mechanism of stabilizing available b-catenin to response elements. We favour a mode of active stabilization of b-catenin occupancy rather than an action that destabilizes the interaction between TCFs and TLE corepressors because the HCT116 cells used in our studies do not have any detectable TLE proteins [16] .
We also demonstrate that the functional outcome of RNF14 activity is colon cancer cell survival and Wnt target gene regulation during zebrafish development. These findings highlight RNF14 as a therapeutic target for colon cancer and other diseases linked to Wnt signalling. RNF14 itself is an E3 ubiquitin ligase and it will be essential to identify its target substrates and test for those involved in Wnt signalling. There are other ubiquitinationrelated co-activators recruited to Wnt target genes, including Trabid that deubiquitinates adenomatous polyposis coli [17] , and the E3 ubiquitin ligase TBL1 that interacts with b-catenin [18] , and the E3 ubiquitin ligase XIAP targets TLE protein [19] . The evolving picture is that TCF and b-catenin recruit a group of factors with several connections to ubiquitin-based activities. It will be important to sort out how these activities and interactions use ubiquitin as a ubiquitin network might lie at the core of Wnt target gene regulation.
METHODS
Zebrafish study. Full-length and deleted rnf14-coding sequences fused to mCherry were subcloned into pCS2 þ . pCS2-b-catenin was a gift from Dr B Gumbiner (University of Virginia). mRNAs were synthesized using the mMESSAGE mMACHINE SP6 kit (Ambion), and 100 pg per embryo was injected at the 1-2 cell stage into TOPdGFP transgenics or wild-type embryos for in situ hybridization. Whole-mount RNA in situ hybridization was performed as previously described [20] . The Otx2 probe was synthesized with T7 RNA polymerase. Embryos were mounted on coverslips and images were taken using a Zeiss Axioplan 2 microscope. An antisense MO (Gene Tools Inc.) was designed targeting the translation start site of Rnf14. The target sequence was fused 5 0 to mCherry-coding sequences and subcloned into pCS2 þ to generate a reporter RNA to test for MO-knockdown efficiency. Cell growth and clonogenic assays. HCT116 and DLD1 cells were pre-treated with siRNA for 48 h and grown for 1 week with addition of fresh siRNA-containing media every 2 days. Cells were RNF14 is a new co-activator of TCF/b-catenin complex B. Wu et al scientific report fixed with 50% trichloroacetic acid and stained with 0.4% (w/v) sulphorhodamine B as described [21] . Optical density readings were performed at 450 nm with a DTX800 multimode detector (Beckman Coulter). For clonogenic assays, cells were pre-treated with siRNA for 48 h. One hundred cells were placed on 10-cm plastic dishes and grown for 10 days. More siRNA was added to DLD1 cells during the course of the experiment. For the rescue experiment, an expression vector for a TCF4-b-catenin fusion protein was transiently transfected into siRNA-treated HCT116 cells for 48 h to knockdown RNF14. After 24 h, 200 cells were placed on 10-cm dishes and grown for 2 weeks. 0.2% crystal violet was used to fix and stain the cells. Colonies with more than 50 cells were counted. Individual colonies were photographed under a Nikon ECLIPSE TE2000U microscope. Chromatin immunoprecipitation. ChIP experiments were performed as described previously [22] . Four micrograms of anti-b-catenin (BD Bioscience), anti-TCF4 (Cell Signaling), anti-Flag (Sigma) and anti-ubiquitinated histone H2B Lys123 (MediMabs) were used for the b-catenin, TCF4, Flag-RNF14 and ubiquitinated H2B ChIPs, respectively. Quantitative PCR analysis was used to quantify the ChIP DNA. The ChIP signal was subtracted by values of the background IgG ChIP and then normalized to input. Extra methods are listed in the Supplementary Materials. ORFs, open reading frames; RNF14, Ring Finger Protein 14; siRNA, short interfering RNA; TCF, T-cell factor; WREs, Wnt-responsive elements.
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